DelveInsight’s “Bipolar Depression Market Insights and Forecast Report” delivers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression market trends, pipeline scenario, Bipolar Depression market drivers, barriers, and forecasted analysis in the 7MM for the study period 2019-32.
Some Facts of Bipolar Depression Market:
Scope of the Bipolar Depression Market Report:
Request for Free Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market
Bipolar Depression (Manic depression) is categorized by recurrent-shifts in the mood/temper and is a manic-depressive disorder hindering the routine life of an individual.
The American Psychiatric Association categorizes Bipolar Depression into four major types of Bipolar Depression: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar Depression due to another medical or substance abuse disorder.
Bipolar Depression affects about 45 million people worldwide, says WHO.
Bipolar Depression Market: Marketed, and Upcoming Drugs
FDA-approved agents for the acute treatment of bipolar depression include Olanzapine-fluoxetine combination, Lurasidone, and Quetiapine.
Other off-label therapies present in the Bipolar Depression market are Anticonvulsants (such as Divalproex and lamotrigine), olanzapine monotherapy, and Lithium and lamotrigine combined therapy.
The Bipolar Depression market report covers detailed picture of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The report helps in providing a better understanding of clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Bipolar Depression Drugs Covered are:
Some of the Key Bipolar Depression Companies Covered:
Bipolar Depression Report Highlights
Table of Contents
1. Key Insights
2. Executive Summary of Bipolar Depression
3. Competitive Intelligence Analysis for Bipolar Depression
4. Bipolar Depression: Market Overview at a Glance
5. Bipolar Depression: Disease Background and Overview
6. Patient Journey
7. Bipolar Depression Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Bipolar Depression Treatment
11. Marketed Products
12. Emerging Therapies
13. Bipolar Depression: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bipolar Depression
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market